ArticleOncology letters2017

Recombinant human adenovirus-p53 improves the outcome of mid-late stage pancreatic cancer via arterial infusion.

Jinggang Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.